---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037627"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:41:46.687724+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pure Bioscience secures up to $3M in convertible notes; initial $500k from director Tom Y. Lee

## Summary
- Initial tranche of $500,000 convertible promissory note placed with director Tom Y. Lee (affiliates).
- Notes bear 7.88% annual interest, mature 3 years; convertible into common at VWAP floor $0.095, cap $0.175.
- Company may conduct subsequent closings up to $3.0 million aggregate principal through July 31, 2025.
- Conversion triggers include automatic conversion one year after issuance at option of majority holders, and upon corporate transactions.
- Offering is exempt from registration under Section 4(a)(2) of the Securities Act.

## SEC filing metadata
- accession: 0001493152-24-037627
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315224037627/0001493152-24-037627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315224037627/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037627
- JSON: https://secwatch.observer/filing/0001493152-24-037627.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.